OTCM
CEOS
Market cap114kUSD
Jul 09, Last price
0.01USD
1D
0.00%
1Q
73.91%
Jan 2017
-20.79%
IPO
-97.33%
Name
CeCors Inc
Chart & Performance
P/E
0.04
P/S
—
EPS
0.22
Div Yield, %
—
Shrs. gr., 5y
10.28%
Rev. gr., 5y
206.78%
Revenues
0k
-100.00%
Net income
3m
P
CFO
1m
-50.70%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Psykey, Inc. is dedicated to the exploration, formulation, and market introduction of specialized ingredients and compounds, including entheogenic, adaptogenic, and nootropic substances. These are incorporated into its functional product lines, which aim to enhance and optimize overall well-being. Furthermore, the company develops cutting-edge technologies focused on the makeup, bioavailability, and targeted administration of entheogen-derived therapeutics within the burgeoning psychedelic industry. Among its consumer offerings are functional mushroom coffees and teas, a variety of oral supplements, and convenient single-serve beverage mixes. The entity, which was established in Toronto, Canada, in 2002, previously operated as CeCors, Inc. before officially adopting the name Psykey, Inc. in August 2021.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||